Friday, July 10, 2026

Drug profile · INN

ethiodized oil

ethiodized oil (LIPIODOL) is a diagnostic agent. Route of administration: intralymphatic, intrauterine. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — ethiodized oil
US status
approved
Class
Route
INTRALYMPHATIC, INTRAUTERINE
Patents
0
Programs
2
Data quality
0.84

Quick answer

ethiodized oil (LIPIODOL) is a diagnostic agent. Route of administration: intralymphatic, intrauterine. Current US regulatory status: approved.

Key facts

INN ethiodized oil
Brand LIPIODOL
Mechanism Diagnostic agent
Route INTRALYMPHATIC, INTRAUTERINE
Formulation OIL

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. ISRCTN12053408 Phase 3 · Ningbo Cancer Hospital · Intermediate stage Hepatocellular carcinoma
  2. VISIPAQUE d’I/mL for Knee OsteoArthritis Phase 3 · PARItec · Knee OsteoArthritis

Frequently asked questions

What is ethiodized oil?

ethiodized oil (LIPIODOL) is a diagnostic agent. Route of administration: intralymphatic, intrauterine. Current US regulatory status: approved.

What is the brand name for ethiodized oil?

LIPIODOL is a marketed brand name for ethiodized oil. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ethiodized oil?

ethiodized oil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.